THYROCARE.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 11:59):

Stats
Dagens volum	20 674.00
Gjennomsnittsvolum	115 686
Markedsverdi	34.45B
EPS	INR0 ( 2024-02-01 )
Neste inntjeningsdato	( INR0 ) 2024-05-21
Last Dividend	INR18.00 ( 2023-04-20 )
Next Dividend	INR0 ( N/A )
P/E	53.11
ATR14	INR0.235 (0.04%)

Volum Korrelasjon

Lang: 0.08 (neutral)

Kort: 0.49 (neutral)

Signal:(29.164) Neutral

Thyrocare Technologies Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Thyrocare Technologies Korrelasjon - Valuta/Råvare

-0.08
( neutral )

0.23
( neutral )

0.00
( neutral )

-0.31
( neutral )

0.08
( neutral )

-0.25
( neutral )

Thyrocare Technologies Økonomi

Annual	2022
Omsetning:	INR5.27B
Bruttogevinst:	INR3.63B (69.01 %)
EPS:	INR12.16

FY	2022
Omsetning:	INR5.27B
Bruttogevinst:	INR3.63B (69.01 %)
EPS:	INR12.16

FY	2022
Omsetning:	INR5.89B
Bruttogevinst:	INR4.19B (71.18 %)
EPS:	INR33.30

FY	2021
Omsetning:	INR4.95B
Bruttogevinst:	INR3.31B (66.86 %)
EPS:	INR21.41

Financial Reports:

No articles found.

Thyrocare Technologies Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR18.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Thyrocare Technologies Dividend Information - Dividend Junior

Dividend Sustainability Score: 2.68 - low (50.00%) | Divividend Growth Potential Score: 5.08 - Potential for dividend initiation, but uncertain (1.67%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR2.50	2016-09-01
Last Dividend	INR18.00	2023-04-20
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	11	--
Total Paid Out	INR105.50	--
Avg. Dividend % Per Year	1.39%	--
Score	2.33	--
Div. Sustainability Score	2.68
Div.Growth Potential Score	5.08
Div. Directional Score	3.88	--

Next Divdend (Est)
(2024-06-24)

INR19.97 Estimate 3.36 %

Dividend Stability

0.27 Very Poor

Dividend Score

2.33

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR10.00	1.55%
2019	INR25.00	4.64%
2020	INR10.00	1.85%
2021	INR15.00	1.60%
2022	INR15.00	1.35%
2023	INR18.00	2.94%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SHALBY.NS	Dividend Junior	2023-08-08	Annually	6	0.51%
MANALIPETC.NS	Dividend Junior	2023-09-15	Annually	18	1.50%
GPPL.NS	Dividend Knight	2023-07-26	Semi-Annually	9	2.89%
AXISBANK.NS	Dividend Junior	2023-07-06	Sporadic	26	0.06%
TRU.NS	Dividend Junior	2023-09-18	Annually	3	0.01%
PIXTRANS.NS	Dividend Junior	2023-07-11	Semi-Annually	3	0.43%
JKLAKSHMI.NS	Dividend Junior	2023-08-11	Annually	18	0.50%
DHRUV.NS	Dividend Junior	2023-09-05	Insufficient data to determine frequency	2	0.15%
SOBHA.NS	Dividend Junior	2023-07-28	Annually	18	0.43%
MMP.NS	Dividend Junior	2023-08-18	Annually	4	0.49%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.118	1.500	7.63	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.128	1.500	9.69	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	24.85	1.000	1.909	1.909	[3 - 30]
operatingCashFlowPerShareTTM	16.82	2.00	4.39	8.79	[0 - 30]
freeCashFlowPerShareTTM	16.82	2.00	1.590	3.18	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.708	1.000	1.541	1.541	[0.2 - 0.8]
operatingProfitMarginTTM	0.168	1.000	8.63	8.63	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				2.68

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	52.64	1.000	4.78	0	[1 - 100]
returnOnEquityTTM	0.128	2.50	9.80	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	16.82	2.00	4.39	3.18	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	16.82	2.00	4.39	8.79	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.948	1.500	7.01	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.161	1.000	8.48	0	[0.1 - 0.5]
Total Score				5.08

Thyrocare Technologies

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.